| Quarterly Financials | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 9 | 6 | 8 | 10 | 9 | 9 | 10 | 7 | 21 | 14 | 16 | 12 | 36 | 25 | 33 | 30 | 52 | 34 |
| Expenses | 7 | 5 | 6 | 7 | 7 | 7 | 8 | 6 | 17 | 11 | 11 | 8 | 26 | 18 | 25 | 21 | 39 | 25 |
| EBITDA | 2 | 1 | 2 | 2 | 3 | 2 | 3 | 2 | 4 | 4 | 5 | 5 | 10 | 7 | 9 | 10 | 13 | 9 |
| Operating Profit % | 20 % | 14 % | 18 % | 21 % | 23 % | 20 % | 22 % | 20 % | 12 % | 19 % | 26 % | 34 % | 25 % | 22 % | 22 % | 20 % | 22 % | 25 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 2 | 1 | 3 | 1 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 3 | 4 | 4 | 6 | 4 | 7 | 6 | 11 | 7 |
| Tax | -1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 2 | 1 | 4 | 2 |
| Net Profit | 3 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 3 | 3 | 6 | 3 | 5 | 5 | 7 | 5 |
| EPS in ₹ | 15.02 | 0.88 | 1.15 | 1.77 | 1.72 | 1.22 | 1.48 | 0.94 | 1.41 | 1.99 | 2.69 | 2.42 | 6.15 | 2.66 | 4.27 | 3.72 | 5.76 | 4.27 |
Trident Lifeline
Trident Lifeline
262.90
0.00
(0.00%)
Market Cap
313.70 Cr
PE Ratio
14.52
Volume
0.00
Day High - Low
267.70 - 261.00
52W High-Low
328.00 - 229.95
Key Fundamentals
Market Cap
313.70 Cr
EPS
16.32
PE Ratio
14.52
PB Ratio
3.12
Book Value
84.14
EBITDA
28.11
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
15.07
Debt to Equity
0.62
Actual
Company News
View All News
Trident Lifeline Limited reported a 44% YoY rise in standalone net profit to ₹5.02 crore for Q1FY26, driven by strong revenue growth across its healthcare and pharma subsidiaries.
Trident Lifeline Limited secured shareholder approval for two director appointments and a migration to the main board via postal ballot. The resolutions passed with 100% of votes in favour.
Trident Lifeline's stake in subsidiary Trident Mediquip fell to 58.67% after a private placement. The transaction was executed at arm's length.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,990.50 | #1 4,77,587.60 | 39.39 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 66.37 | |
8,056.00 | 2,13,861.50 | 83.29 | 11,067.00 | 13.95 | 2,568 | 65.50 | 82.30 | |
5,122.80 | 1,94,854.80 | 90.03 | 13,886.20 | 20.34 | 2,138 | 3.28 | 64.10 | |
1,473.20 | 1,19,011.80 | 35.46 | 29,044.60 | 2.24 | 3,870 | -39.18 | 61.43 | |
1,126.80 | 1,13,382.40 | 21.93 | 27,657.90 | 17.64 | 5,026 | 7.82 | 53.10 | |
2,415.00 | 1,10,421.70 | #1 20.61 | 29,038.90 | #1 26.75 | 5,356 | 87.72 | 49.50 | |
2,469.60 | 1,01,993.50 | 49.34 | 14,636.40 | 14.85 | 1,938 | 29.13 | 44.89 | |
1,816.20 | 98,048.80 | 90.00 | 6,867.80 | 22.01 | 890 | #1 123.93 | 81.68 | |
1,148.10 | 95,828.40 | 30.09 | 35,058.60 | 3.90 | 4,158 | -69.10 | 28.48 | |
1,580.20 | 90,921.20 | 26.19 | 33,384.70 | 3.21 | 3,376 | 1.99 | 57.35 |
Growth Rate
Revenue Growth
35.53 %
Net Income Growth
83.14 %
Cash Flow Change
-559.19 %
ROE
36.88 %
ROCE
23.42 %
EBITDA Margin (Avg.)
-16.20 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 14 | 63 | 87 | 156 | 237 |
| Fixed Assets | 1 | 3 | 21 | 44 | 73 |
| Current Assets | 11 | 49 | 52 | 90 | 140 |
| Capital Work in Progress | 0 | 5 | 4 | 2 | 18 |
| Investments | 0 | 0 | 0 | 0 | 36 |
| Other Assets | 12 | 55 | 62 | 111 | 0 |
| Total Equity & Liabilities | 14 | 63 | 87 | 156 | 237 |
| Current Liabilities | 8 | 12 | 20 | 54 | 88 |
| Non Current Liabilities | 2 | 4 | 13 | 33 | 41 |
| Total Equity | 5 | 47 | 54 | 70 | 100 |
| Reserve & Surplus | -3 | 34 | 40 | 53 | 89 |
| Share Capital | 8 | 12 | 12 | 12 | 12 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 14 | -7 | -4 |
| Investing Activities | -0 | -10 | -20 | -14 |
| Operating Activities | -0 | -19 | 2 | -10 |
| Financing Activities | 1 | 42 | 11 | 20 |
Share Holding
| % Holding | Aug 2022 | Sept 2022 | Oct 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 100.00 % | 69.57 % | 69.57 % | 69.85 % | 69.99 % | 70.04 % | 70.04 % | 70.04 % | 67.48 % | 65.51 % | 62.99 % | 62.99 % | 63.04 % | 63.04 % | 63.11 % | 64.11 % | 62.85 % | 62.59 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 4.64 % | 6.02 % | 6.02 % | 6.09 % | 6.09 % | 6.62 % | 7.21 % | 7.71 % | 7.04 % | 7.24 % | 5.25 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.09 % | 0.39 % | 0.41 % | 0.35 % | 0.27 % | 0.26 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 23.18 % | 23.18 % | 15.13 % | 13.38 % | 14.30 % | 14.82 % | 14.43 % | 16.39 % | 18.37 % | 19.40 % | 18.90 % | 18.26 % | 17.90 % | 17.63 % | 17.29 % | 18.67 % | 20.58 % |
| Others | 0.00 % | 7.25 % | 7.25 % | 15.02 % | 16.63 % | 15.66 % | 15.14 % | 10.88 % | 10.10 % | 10.10 % | 11.52 % | 12.02 % | 11.99 % | 11.45 % | 11.14 % | 11.22 % | 10.97 % | 11.31 % |
| No of Share Holders | 0 | 10 | 1,389 | 397 | 388 | 387 | 439 | 481 | 500 | 502 | 507 | 523 | 534 | 549 | 554 | 549 | 607 | 709 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Sept 2024 |  Annual General Meeting | NA | 20 Sept 2024 | 266.00 | 314.00 |
| 19 Oct 2024 |  Quarterly Result Announcement | NA | 19 Oct 2024 | 284.95 | 299.00 |
| 22 Jan 2025 | Quarterly Result Announcement | NA | 22 Jan 2025 | 266.00 | 281.50 |
| 28 Apr 2025 | Quarterly Result Announcement | NA | 28 Apr 2025 | 270.00 | 284.00 |
| 09 May 2025 |  Extraordinary General Meeting | NA | 09 May 2025 | 252.65 | 287.00 |
| 28 Jul 2025 | Quarterly Result Announcement | NA | 28 Jul 2025 | 270.00 | 273.20 |
| 27 Sept 2025 | Annual General Meeting | NA | 27 Sept 2025 | 297.05 | 296.00 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 296.50 | 300.75 |
| 17 Jan 2026 | Quarterly Result Announcement | NA | 17 Jan 2026 | 290.00 | 306.75 |
| 07 May 2026 | Quarterly Result Announcement | NA | 07 May 2026 | 252.15 | 249.70 |
| 29 Jul 2026 | Quarterly Result Announcement | NA | 29 Jul 2026 | 263.70 | 264.25 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 days ago
2 days agoResult- Financial Result For Quarter Ended 30.06.20264 days ago
4 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On 29.07.20264 days ago
4 days agoBoard Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2026.9 days ago
9 days agoShareholder Meeting / Postal Ballot-Outcome of Postal_BallotJul 17, 2026
Jul 17, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 17, 2026
Jul 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2026
Jul 10, 2026Closure of Trading WindowJun 27, 2026
Jun 27, 2026Announcement under Regulation 30 (LODR)-AcquisitionJun 16, 2026
Jun 16, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 15, 2026
Jun 15, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 15, 2026
Jun 15, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 15, 2026
Jun 15, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJun 13, 2026
Jun 13, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On Saturday June 13 2026 In Terms Of Second Proviso To Regulation
30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 13, 2026
Jun 13, 2026Announcement under Regulation 30 (LODR)-AcquisitionJun 09, 2026
Jun 09, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 05, 2026
Jun 05, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 09, 2026
May 09, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 09, 2026
May 09, 2026Appointment Of Internal AuditorMay 07, 2026
May 07, 2026Result- Financial Result For Half Year And Year Ended On 31.03.2026May 07, 2026
May 07, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On May 07 2026May 07, 2026
May 07, 2026Update on board meetingMay 04, 2026
May 04, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Apr 30, 2026Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Half Year And Year Ended 31St March 2026Apr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-AcquisitionApr 24, 2026
Apr 24, 2026Announcement under Regulation 30 (LODR)-AcquisitionApr 17, 2026
Apr 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Apr 08, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 02, 2026
Apr 02, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 02, 2026
Apr 02, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 01, 2026
Apr 01, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 01, 2026
Apr 01, 2026Closure of Trading WindowMar 31, 2026
Mar 31, 2026Outcome Of Separate Meeting Of Independent Directors Held On 28.03.2026Mar 28, 2026
Mar 28, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 27, 2026
Mar 27, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-AcquisitionMar 18, 2026
Mar 18, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 16, 2026
Mar 16, 2026Announcement under Regulation 30 (LODR)-AcquisitionMar 03, 2026
Mar 03, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 23, 2026
Feb 23, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 23, 2026
Feb 23, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 16, 2026
Feb 16, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 03, 2026
Feb 03, 2026Announcement under Regulation 30 (LODR)-AcquisitionFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 20, 2026
Jan 20, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 19, 2026
Jan 19, 2026Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended 31.12.2025Jan 17, 2026
Jan 17, 2026Result- Financial Results For The Quarter And Nine Months Ended 31St December 2025Jan 17, 2026
Jan 17, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 17.01.2026Jan 17, 2026
Jan 17, 2026Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended 31St December 2025;Jan 13, 2026
Jan 13, 2026Technical Indicators
RSI(14)
Neutral 53.08
ATR(14)
Less Volatile 7.25
STOCH(9,6)
Neutral 48.68
STOCH RSI(14)
Neutral 76.27
MACD(12,26)
Bullish 0.06
ADX(14)
Strong Trend 33.03
UO(9)
Bearish 35.85
ROC(12)
Uptrend And Accelerating 2.68
WillR(14)
Neutral -48.39
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
